Hamill, Richard J.

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 2,660

Amphotericin B formulations: a comparative review of efficacy and toxicity

Hamill, R. J. (2013) · Drugs

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 807

Cryptococcosis: Population‐Based Multistate Active Surveillance and Risk Factors in Human Immunodeficiency Virus–Infected Persons

Hajjeh, R. A., Conn, L. A., Stephens, D. S., Baughman, W., Hamill, R., Graviss, E., Pappas, P. G., Thomas, C., Reingold, A., Rothrock, G., et al. (1999) · The Journal of Infectious Diseases

Fungal Infections and StudiesPneumocystis jirovecii pneumonia detection and treatment

Cited by 275

Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis

Pappas, P. G., Bustamante, B., Ticona, E., Hamill, R. J., Johnson, P. C., Reboli, A., Aberg, J., Hasbun, R., & Hsu, H. H. (2004) · The Journal of Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 202

Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae

Carlson-Banning, K. M., Chou, A., Liu, Z., Hamill, R. J., Song, Y., & Zechiedrich, L. (2013) · PLoS ONE

Antibiotic Resistance in BacteriaAntimicrobial agents and applications

Cited by 73